Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-03-08-Speech-2-257-250"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-03-08"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"lt"^^xsd:language2
lpv:document identification number	"en.20110308.22.2-257-250"2
lpv:hasSubsequent	lp_eu:2011-03-08-Speech-2-257-0002
lpv:speaker	lp:Rolandas Paksas2
lpv:spokenAs	vice-chair_member_of_the_bureau; EFD (2010-02-16--2012-01-26)3 member; Delegation for relations with the People's Republic of China (2009-09-16--2014-06-30)3 member; PETI (2009-07-16--2012-01-18)3 member; Special Committee on the Financial, Economic and Social Crisis (2009-10-08--2011-07-31)3 unknown; Partija Tvarka ir teisingumas (2009-07-14--2014-06-30)3 member; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees, and for relations with Tajikistan, Turkmenistan and Mongolia (2009-09-16--2014-06-30)3 member; ECON (2009-07-16--2012-01-18)3 substitute; ITRE (2009-07-16--2012-01-18)3
lpv:translated text	"I voted in favour of this resolution, because it is difficult to predict the severity of a pandemic and how it will unfold, and often when a pandemic occurs, many decisions are taken that are disproportionate. Therefore, it is necessary to pay significant attention to ensuring cooperation, independence and transparency. Above all, the prevention plans established both in the EU and its Member States for future influenza pandemics must be revised consistently, so that they are flexible and adapted effectively every time there is a risk of a flu pandemic. Furthermore, we must encourage cooperation and coordination of action at international and regional levels in order to properly ensure risk management and react promptly to the risk of a pandemic. I believe that more financial resources need to be allocated to research and development, and to that end we need to increase investment to evaluate and anticipate the impact of an influenza virus. It is important to ensure that the prior purchase agreement and delivery process takes place transparently, reducing corruption in this area. We must limit the influence of pharmaceutical companies, not just as regards distribution, but also the carrying out of studies into vaccines and antiviral medications. Scientific experts should declare publicly that they have no financial or other interests in the pharmaceutical industry."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph